DoriVac

DoriVac is a biotechnology company developing a modular DNA origami-based vaccine platform designed to transform cancer immunotherapy and infectious disease prevention. Spun out from the Wyss Institute at Harvard University, the company utilizes self-assembling DNA nanostructures to precisely control the spatial arrangement and stoichiometry of antigens and adjuvants. This nanoscopic precision allows for the optimized stimulation of dendritic cells, leading to robust T-cell responses and enhanced anti-tumor activity. The platform is highly versatile, enabling the rapid development of personalized cancer vaccines and broad-spectrum infectious disease candidates.